Y-Y Wu

666 citations

12 papers · 553 indexed · h-index 7

Impact in

Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Molecular Biology
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing

Papers in ⓘ

Molecular Biology 6
- Circular RNAs in diseases 3
- RNA modifications and cancer 2
- Signaling Pathways in Disease 1
Cancer Research 4
- Cancer-related molecular mechanisms research 3
- MicroRNA in disease regulation 2

Co-authors: Rui Xie (2 shared papers)Shu‐Mei Wang (2 shared papers)Yang Sm (2 shared papers)Bin Tang (1 shared paper)Cheng‐Wen Lin (1 shared paper)Wang Ym (1 shared paper)Ping‐Ning Hsu (1 shared paper)Ching‐Yu Chen (1 shared paper)
Journals: Oncogene (2 papers)British Journal of Cancer (1 paper)Spinal Cord (1 paper)Cell Death and Disease (1 paper)Clinical & Experimental Immunology (1 paper)
Partner nations: China Taiwan Pakistan

In The Last Decade

Y-Y Wu

12 papers receiving 547 citations

Peers

Countries citing papers authored by Y-Y Wu

Since Specialization

Citations

This map shows the geographic impact of Y-Y Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y-Y Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y-Y Wu more than expected).

Fields of papers citing papers by Y-Y Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y-Y Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y-Y Wu. The network helps show where Y-Y Wu may publish in the future.

Co-authors

The 25 scholars most cited alongside Y-Y Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Y-Y Wu Line = papers co-authored together Y-Y Wu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work
1	Long noncoding RNA BC032469, a novel competing endogenous RNA, upregulates hTERT expression by sponging miR-1207-5p and promotes proliferation in gastric cancer Oncogene ·Lu Mh, Bin Tang, S Zeng, C-J Hu, Rui Xie, Y-Y Wu, Shu‐Mei Wang, F-T He, Yang Sm	2015	157
2	GSK3β controls epithelial–mesenchymal transition and tumor metastasis by CHIP-mediated degradation of Slug Oncogene ·S-H Kao, Wang Wl, Ching‐Yu Chen, Yih‐Leong Chang, Y-Y Wu, Y-T Wang, S-P Wang, Alexey I. Nesvizhskii, Yu‐Ju Chen, T-M Hong, Pan‐Chyr Yang	2013	115
3	miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase Cell Death and Disease ·Lingxi Chen, Lu Mh, David Zhang, N-B Hao, Yanhui Fan, Y-Y Wu, Shu‐Mei Wang, Rui Xie, D‐c. Fang, H Zhang, C-J Hu, Yang Sm	2014	109
4	Increased programmed death-ligand-1 expression in human gastric epithelial cells inHelicobacter pyloriinfection Clinical & Experimental Immunology ·Y-Y Wu, Cheng‐Wen Lin, K-S Cheng, Wang Ym, I-T Lin, Y‐H Chou, Ping‐Ning Hsu	2010	74
5	Clinical-guide risk prediction of hepatocellular carcinoma development in chronic hepatitis C patients after interferon-based therapy British Journal of Cancer ·KC Chang, Y-Y Wu, Chien‐Hui Hung, SN Lu, Chi‐Ming Lee, King‐Wah Chiu, M-C Tsai, Po‐Lin Tseng, C-M Huang, Chung‐Lung Cho, Chien‐Jen Chen, T-H Hu	2013	49
6	Optimal time window of myelotomy in rats with acute traumatic spinal cord injury: a preliminary study Spinal Cord ·D-G Yang, Jingjia Li, Ruolei Gu, M-L Yang, X Zhang, L-J Du, Wei Sun, Feng Gao, A-M Hu, Y-Y Wu, J-G He, Y-T Feng, H-Y Chu	2013	16
7	Effect of miR-7 on resistance of breast cancer cells to adriamycin via regulating EGFR/PI3K signaling pathway. PubMed ·Qiong Huang, Y-Y Wu, Xing Sj, Yu Zw	2019	14
8	Effect of TNF-alpha on endometrial glucose transporter-4 expression in patients with polycystic ovary syndrome through nuclear factor-kappa B signaling pathway activation. PubMed ·L-X Ha, Y-Y Wu, T Yin, Y-Y Yuan, Y-D Du	2021	6
9	[The expression of long non-coding RNA LINC00261 in laryngeal carcinoma tissue and their clinical significance]. PubMed ·Zhang Cm, Gao W, Y-Y Wu, Zhao Ql, B Chen, Liu Qq, Li Wy, Wen Sx, Wang Bq	2017	6
10	A Method of Utrophin Up-Regulation through RNAi-Mediated Knockdown of the Transcription Factor EN1 Journal of International Medical Research ·Qing Wang, Donghao Cao, C-L Jin, C-K Lin, H-W Ma, Y-Y Wu	2011	5
11	IL-17A as a new circulating bioindicator for non-small cell lung cancer diagnosis and prognosis. PubMed ·Jianxun Wang, X-J Xu, Zhu Zm, W-L Cao, Z-P Yang, J-L Zhen, Y-Y Wu, F-M Lu, S-W. Liu	2023	1
12	[Clinical analysis of 9 cases with Anti-leucine-rich glioma inactivated 1 protein antibody associated limbic encephalitis]. PubMed ·Zhang Yx, Yang Hl, Y-Y Wu, Wang Cc, Gao Xy, Yongyong Shi, Liu Hq, Yan Huang, Zhang Jw	2017	1

About Y-Y Wu

Y-Y Wu is a scholar working on Molecular Biology, Cancer Research, Surgery, Oncology and Immunology, having authored 12 papers that have together received 553 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (3 papers), Circular RNAs in diseases (3 papers), MicroRNA in disease regulation (2 papers), RNA modifications and cancer (2 papers), Nerve injury and regeneration (1 paper), Signaling Pathways in Disease (1 paper), Cytokine Signaling Pathways and Interactions (1 paper) and Galectins and Cancer Biology (1 paper). The work is most often cited by research in Cancer Research (282 citations), Molecular Biology (383 citations), Hepatology (44 citations), Oncology (105 citations) and Immunology (59 citations). Y-Y Wu has collaborated with scholars based in China, Taiwan and Pakistan. Frequent co-authors include Rui Xie, Shu‐Mei Wang, Yang Sm, Bin Tang, Cheng‐Wen Lin, Wang Ym, Ping‐Ning Hsu, Ching‐Yu Chen, Yih‐Leong Chang and Yu‐Ju Chen. Their work appears in journals such as Oncogene, British Journal of Cancer, Spinal Cord, Cell Death and Disease and Clinical & Experimental Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact